A 12-week efficacy and safety study of two doses of mometasone/formoterol combination formulation compared with mometasone monotherapy, in persistent asthmatics previously treated with high-dose inhaled glucocorticosteroids.

Trial Profile

A 12-week efficacy and safety study of two doses of mometasone/formoterol combination formulation compared with mometasone monotherapy, in persistent asthmatics previously treated with high-dose inhaled glucocorticosteroids.

Completed
Phase of Trial: Phase III

Latest Information Update: 20 Apr 2017

At a glance

  • Drugs Mometasone/formoterol (Primary) ; Mometasone
  • Indications Asthma
  • Focus Therapeutic Use
  • Acronyms COMPLETED
  • Sponsors Schering-Plough
  • Most Recent Events

    • 07 Nov 2012 Planned number of patients changed from 414 to 621.
    • 18 May 2011 Secondary endpoint 'Daytime-symptom-score' has been met.
    • 18 May 2011 Secondary endpoint 'Night-time-symptom-score' has been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top